The Dose Debate


XR-29 evolved after MITA and its partner organizations identified components that most providers could use right now. “We didn’t want to write a standard that nobody could comply with or that nobody could meet,” Rodriguez said. “But again, we didn’t want to make it so basic that everyone was already meeting it. We wanted to drive them to use these new features. That’s how we came at that balance.”


Click here to read the full article.